Drug
Roluperidone
Roluperidone: highest development phase Phase 3, developed by Minerva Neurosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Minerva Neurosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Roluperidone NCT07565428 | Phase 3 | Negative Symptoms of Schizophrenia |
Latest
No recent events.
Follow Roluperidone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.